Medivolve Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CAD 0.288781 million compared to CAD 0.073202 million a year ago. Net loss was CAD 0.931996 million compared to CAD 2.91 million a year ago.

Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.06 a year ago. Diluted loss per share from continuing operations was CAD 0.02 compared to CAD 0.06 a year ago.